Delivery Order SPE2DR25D1103-SPE2DR26FD793
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Fluticasone Propionate HFA 220 micrograms in 12-gram inhalers, valued at $11,581.53. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of October 24, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, with a ceiling value of $1,504.06. This firm fixed-price delivery order, which was competitively awarded without a set-aside designation, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework. The contract specifies Conshohocken, Pennsylvania as the place of...
- The Defense Logistics Agency awarded a delivery order valued at $2,108.90 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Fluticasone Propionate HFA 110 mcg inhalers (12 grams), with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the company's location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $1,189.14 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 220 micrograms in 12-gram inhalers. This competitively awarded, firm fixed-price order was placed on November 6, 2025, with an ultimate completion date of November 7, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $4,535.86 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fluticasone Propionate HFA 220 MCG inhalers (12 grams). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Fluticasone Propionate HFA 44 micrograms in 10.6-gram inhalers, with a ceiling value of $4,633.71. This competitive award, utilizing firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 billion through December 2026. The order is set to be completed by...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Fluticasone Propionate HFA 220 micrograms in a 12-gram inhaler. This competitively awarded, non-set-aside contract carries a ceiling value of $3,753.01 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 14, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Fluticasone Propionate HFA 44 micrograms in 10.6-gram inhalers, with a contract ceiling value of $5,882.40. This competitive, non-set-aside delivery order represents a firm fixed price procurement with an ultimate completion date of November 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for Fluticasone Propionate HFA 220 micrograms in a 12-gram inhaler, with a ceiling value of $3,269.72 and a completion date of July 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning the award was made through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 mcg inhalers (10.6 grams) valued at $1,225.92. This non-competitive delivery order was awarded on October 30, 2025, with an ultimate completion date of October 31, 2025, and reflects a firm fixed-price contract type. The pharmaceutical product will be performed and delivered from AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's corporate headquarters....
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FD793Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,795.88 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Fluticasone Propionate HFA 220 micrograms in 12-gram inhalers. The contract is a firm fixed-price delivery order with a completion deadline of November 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal pharmaceutical procurement requirements. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen regularly fulfills medical procurement needs across multiple therapeutic domains for defense and veteran healthcare systems through the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 11/6/25 |